Adial Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics for addiction and related disorders. Its lead investigational drug candidate, AD04 (ondansetron-based), targets alcohol use disorder (AUD) in patients with specific serotonin transporter and receptor gene polymorphisms, identified via a companion diagnostic genetic test. The company has conducted a Phase 3 trial (ONWARD) and is planning additional Phase 3 trials under FDA guidance for US regulatory approval.
expected 2026-12-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001213900-26-024175 | EDGAR | 87K words |
| 2025-03-04 | 2024-12-31 | 0001213900-25-019771 | EDGAR | 90K words |
| 2024-04-01 | 2023-12-31 | 0001213900-24-028701 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001213900-23-024719 | EDGAR | — |
| 2022-03-28 | 2021-12-31 | 0001213900-22-015562 | EDGAR | — |
| 2021-03-22 | 2020-12-31 | 0001213900-21-017009 | EDGAR | — |
| 2020-03-20 | 2019-12-31 | 0001213900-20-007020 | EDGAR | — |
| 2019-02-19 | 2018-12-31 | 0001213900-19-002769 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001213900-26-090051 | EDGAR | 33K words |
| 2025-11-13 | 2025-09-30 | 0001213900-25-109979 | EDGAR | 21K words |
| 2025-08-13 | 2025-06-30 | 0001213900-25-075695 | EDGAR | 20K words |
| 2025-05-14 | 2025-03-31 | 0001213900-25-043281 | EDGAR | 16K words |
| 2024-11-13 | 2024-09-30 | 0001213900-24-097519 | EDGAR | 19K words |
| 2024-08-13 | 2024-06-30 | 0001213900-24-068262 | EDGAR | 18K words |
| 2024-05-14 | 2024-03-31 | 0001213900-24-043023 | EDGAR | 16K words |
| 2023-11-14 | 2023-09-30 | 0001213900-23-086913 | EDGAR | — |
| 2023-08-21 | 2023-06-30 | 0001213900-23-069141 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001213900-23-038985 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001213900-22-071643 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001213900-22-047638 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-18 | 0001213900-26-101434 | EDGAR | 17K words |
| 2026-09-16 | 0001213900-26-100574 | EDGAR | 2K words |
| 2026-08-25 | 0001213900-26-093544 | EDGAR | 1K words |
| 2026-08-21 | 0001213900-26-092690 | EDGAR | 1K words |
| 2026-08-17 | 0001213900-26-090482 | EDGAR | 2K words |
| 2026-08-13 | 0001213900-26-089270 | EDGAR | 1K words |
| 2026-03-06 | 0001213900-26-024336 | EDGAR | 2K words |
| 2026-03-03 | 0001213900-26-022718 | EDGAR | 2K words |
| 2026-02-24 | 0001213900-26-019639 | EDGAR | 1K words |
| 2026-02-04 | 0001213900-26-012274 | EDGAR | 1K words |
238 total filings indexed. 208 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001513525 |
| Ticker | ADIL |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.adial.com |
| Listed | 2018-07-27 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ADIL (~200 tokens, structured JSON with cryptographic provenance)